| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.101.25.2889 |
| P698 | PubMed publication ID | 10869259 |
| P2093 | author name string | Li D | |
| Mehta JL | |||
| P433 | issue | 25 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 2889-2895 | |
| P577 | publication date | 2000-06-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells | |
| P478 | volume | 101 |
| Q36663149 | 6-Shogaol Protects against Oxidized LDL-Induced Endothelial Injruries by Inhibiting Oxidized LDL-Evoked LOX-1 Signaling |
| Q36596873 | A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications |
| Q28708793 | Air pollution and circulating biomarkers of oxidative stress |
| Q34308238 | Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice |
| Q40055172 | Anti-LOX-1 therapy in rats with diabetes and dyslipidemia: ablation of renal vascular and epithelial manifestations |
| Q42873335 | Antiangiogenic and Antimitotic Effects of Aspirin in Hypoxia–Reoxygenation Modulation of the LOX-1-NADPH Oxidase Axis as a Potential Mechanism |
| Q39637375 | Apigenin inhibits tumor necrosis factor alpha plus high glucose-induced LOX-1 expression in human endothelial cells |
| Q37400830 | Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals |
| Q92021254 | Atherogenic LOX-1 signaling is controlled by SPPL2-mediated intramembrane proteolysis |
| Q38097499 | C-type lectin-like receptors of the dectin-1 cluster: ligands and signaling pathways. |
| Q37790669 | Carbamylated LDL |
| Q74179102 | Changes in the phospholipid composition of the arterial cell can result in severe atherosclerotic lesions |
| Q24297988 | Chaperonin-containing TCP-1 complex directly binds to the cytoplasmic domain of the LOX-1 receptor |
| Q37850239 | Chlamydia pneumoniae binds to the lectin-like oxidized LDL receptor for infection of endothelial cells |
| Q37412127 | Chlamydia pneumoniae induces expression of pro-atherogenic factors through activation of the lectin-like oxidized LDL receptor-1 |
| Q83603579 | Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with angiographic coronary lesion complexity in patients with coronary artery disease |
| Q45045801 | Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels predict percutaneous coronary intervention-related periprocedural myocardial infarction in stable patients undergoing elective native single-vessel PCI. |
| Q24532675 | Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding |
| Q35019922 | Consolidated and emerging inflammatory markers in coronary artery disease |
| Q46278173 | Contribution of lectin-like oxidized low-density lipoprotein receptor-1 and LOX-1 modulating compounds to vascular diseases |
| Q42164926 | Correlation between the extent of coronary atherosclerosis and lipid profile |
| Q37109342 | Cryptotanshinone inhibits oxidized LDL-induced adhesion molecule expression via ROS dependent NF-κB pathways |
| Q36342164 | Cryptotanshinone, an orally bioactive herbal compound from Danshen, attenuates atherosclerosis in apolipoprotein E-deficient mice: role of lectin-like oxidized LDL receptor-1 (LOX-1). |
| Q37979643 | Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis |
| Q36022217 | Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin |
| Q45953889 | Deletion of LOX-1 attenuates renal injury following angiotensin II infusion. |
| Q43129743 | Diallyl disulfide and diallyl trisulfide protect endothelial nitric oxide synthase against damage by oxidized low-density lipoprotein |
| Q37924631 | Do atherosclerosis and obesity-associated susceptibility to cancer share causative link to oxLDL and LOX-1? |
| Q38777318 | Dyslipidemia Part 1--Review of Lipid Metabolism and Vascular Cell Physiology |
| Q55341490 | Efficacy of High-Dose and Low-Dose Simvastatin on Vascular Oxidative Stress and Neurological Outcomes in Patient with Acute Ischemic Stroke: A Randomized, Double-Blind, Parallel, Controlled Trial. |
| Q90611906 | Electronegative low-density lipoprotein of patients with metabolic syndrome induces pathogenesis of aorta through disruption of the stimulated by retinoic acid 6 cascade |
| Q64904443 | Emerging Biomarkers of Oxidative Stress in Acute and Stable Coronary Artery Disease: Levels and Determinants. |
| Q58772933 | Emerging Roles of Sonic Hedgehog in Adult Neurological Diseases: Neurogenesis and Beyond |
| Q28195411 | Endothelial dysfunction: a comprehensive appraisal |
| Q46255902 | Endothelin-converting enzyme-1 increases in atherosclerotic mice: potential role of oxidized low density lipoproteins |
| Q37639902 | Endothelium and its alterations in cardiovascular diseases: life style intervention |
| Q41683007 | Establishment of combined analytical method to extract the genes of interest from transcriptome data |
| Q73158540 | Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction |
| Q36349802 | Extent of flow recirculation governs expression of atherosclerotic and thrombotic biomarkers in arterial bifurcations. |
| Q47681203 | Facilitative interaction between angiotensin II and oxidised LDL in cultured human coronary artery endothelial cells |
| Q30409536 | Flow-dependent cellular mechanotransduction in atherosclerosis |
| Q37773382 | Gender-specific features of plasmatic and circulating cell alterations as risk factors in cardiovascular disease |
| Q35656128 | Gene Expression Profiling of Human Vaginal Cells In Vitro Discriminates Compounds with Pro-Inflammatory and Mucosa-Altering Properties: Novel Biomarkers for Preclinical Testing of HIV Microbicide Candidates |
| Q35664761 | Generation of Adducts of 4-Hydroxy-2-nonenal with Heat Shock 60 kDa Protein 1 in Human Promyelocytic HL-60 and Monocytic THP-1 Cell Lines |
| Q45305398 | Glycocalyx in Atherosclerosis-Relevant Endothelium Function and as a Therapeutic Target |
| Q37716581 | HDL metabolism and activity in chronic kidney disease |
| Q38196219 | Heated vegetable oils and cardiovascular disease risk factors |
| Q64241987 | High Levels of Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 Are Associated With Carotid Plaque Inflammation and Increased Risk of Ischemic Stroke |
| Q46316628 | Higher expression of HSP70 and LOX-1 in the placental tissues of pre-eclampsia pregnancies. |
| Q39061320 | Hsa-let-7g miRNA targets caspase-3 and inhibits the apoptosis induced by ox-LDL in endothelial cells |
| Q39933820 | Human cytomegalovirus-encoded miR-US25-1 aggravates the oxidised low density lipoprotein-induced apoptosis of endothelial cells |
| Q79274591 | Hyperhomocysteinemic Subjects Have Enhanced Expression of Lectin-Like Oxidized LDL Receptor-1 in Mononuclear Cells |
| Q28216302 | Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor |
| Q46160198 | Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease |
| Q35915081 | Infection and Atherosclerosis Development |
| Q35821202 | Infection with Chlamydia pneumoniae as a cause of coronary heart disease: the hypothesis is still untested |
| Q38157558 | Inflammation and atherosclerosis--revisited |
| Q38899088 | Influenza virus aggravates the ox-LDL-induced apoptosis of human endothelial cells via promoting p53 signaling |
| Q35561312 | Inhibition of lectin-like oxidized low-density lipoprotein receptor-1 reduces leukocyte adhesion within the intestinal microcirculation in experimental endotoxemia in rats. |
| Q37466096 | Innate immune activation in obesity |
| Q36938635 | Innate immunity, macrophage activation, and atherosclerosis |
| Q36467559 | Interaction of oxidized low-density lipoprotein and the renin-angiotensin system in coronary artery disease |
| Q45979636 | Isothiocyanates protect against oxidized LDL-induced endothelial dysfunction by upregulating Nrf2-dependent antioxidation and suppressing NFκB activation. |
| Q43642804 | LDL cholesterol angiotensin II interactions in atherosclerosis |
| Q42425533 | LOX-1 Inhibition in ApoE KO Mice Using a Schizophyllan-based Antisense Oligonucleotide Therapy |
| Q33709392 | LOX-1 abrogation reduces cardiac hypertrophy and collagen accumulation following chronic ischemia in the mouse |
| Q37921158 | LOX-1 and angiotensin receptors, and their interplay |
| Q37297831 | LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma |
| Q28565059 | LOX-1 expressed in cultured rat chondrocytes mediates oxidized LDL-induced cell death-possible role of dephosphorylation of Akt |
| Q34079451 | LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. |
| Q28583634 | LOX-1 inhibition in myocardial ischemia-reperfusion injury: modulation of MMP-1 and inflammation |
| Q34712581 | LOX-1 plays an important role in ischemia-induced angiogenesis of limbs |
| Q40376526 | LOX-1 scavenger receptor mediates calcium-dependent recognition of phosphatidylserine and apoptotic cells |
| Q38128283 | LOX-1, OxLDL, and atherosclerosis |
| Q38128195 | LOX-1, a new marker of risk and prognosis in coronary artery disease? |
| Q34774368 | LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis |
| Q38829882 | LOX-1-Mediated Effects on Vascular Cells in Atherosclerosis |
| Q92127537 | LOX-1: Regulation, Signaling and Its Role in Atherosclerosis |
| Q37918860 | LOX-1: a critical player in the genesis and progression of myocardial ischemia |
| Q81405508 | Lectin-like oxidized LDL receptor-1 as extracellular chaperone receptor: its versatile functions and human diseases |
| Q28566134 | Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation |
| Q77578272 | Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE) |
| Q43719523 | Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) supports cell adhesion to fibronectin |
| Q36872076 | Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis? |
| Q38849283 | Lipid Abnormalities and Inflammation in HIV Inflection |
| Q35011105 | Lipid peroxidation modification of protein generates Nepsilon-(4-oxononanoyl)lysine as a pro-inflammatory ligand |
| Q37783424 | Lipotoxicity and Impaired High Density Lipoprotein-Mediated Reverse Cholesterol Transport in Chronic Kidney Disease |
| Q36610465 | Mechanisms for cellular cholesterol transport: defects and human disease |
| Q34763616 | Mesenchymal Stem Cells Ameliorate Atherosclerotic Lesions via Restoring Endothelial Function |
| Q37118124 | MicroRNAs as pharmacological targets in endothelial cell function and dysfunction |
| Q52652318 | MicroRNAs in endothelial cell homeostasis and vascular disease. |
| Q30481046 | Molecular dynamics simulation of human LOX-1 provides an explanation for the lack of OxLDL binding to the Trp150Ala mutant |
| Q30434516 | Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance |
| Q34674199 | New scavenger receptors and their functions in atherogenesis |
| Q43955464 | Nitric oxide prevents oxidised LDL-induced p53 accumulation, cytochrome c translocation, and apoptosis in macrophages via guanylate cyclase stimulation |
| Q37061332 | Ox-LDL promotes migration and adhesion of bone marrow-derived mesenchymal stem cells via regulation of MCP-1 expression |
| Q38026381 | Oxidant stress and skeletal muscle microvasculopathy in the metabolic syndrome |
| Q37009105 | Oxidative Stress and Inflammation Differentially Elevated in Objective Versus Habitual Subjective Reduced Sleep Duration in Obstructive Sleep Apnea |
| Q46305239 | Oxidative Stress in Atherosclerosis |
| Q42910718 | Oxidative Versus Thrombotic Stimulation of Platelets Differentially activates Signalling Pathways |
| Q50981314 | Oxidative stress augments pulmonary hypertension in chronically hypoxic mice overexpressing the oxidized LDL receptor. |
| Q44523793 | Oxidized LDL through LOX-1 modulates LDL-receptor expression in human coronary artery endothelial cells |
| Q37938848 | Oxidized LDL, LOX-1 and atherosclerosis |
| Q42240864 | Oxidized Low Density Lipoprotein and High Sensitive C-Reactive Protein in Non-Diabetic, Pre-Diabetic and Diabetic Patients in the Acute Phase of the First Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention |
| Q38026551 | Oxidized low-density lipoprotein as a biomarker of in vivo oxidative stress: from atherosclerosis to periodontitis |
| Q30405926 | Oxidized low-density lipoprotein contributes to atherogenesis via co-activation of macrophages and mast cells |
| Q38852365 | Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis |
| Q58610763 | Picroside II attenuates hyperhomocysteinemia-induced endothelial injury by reducing inflammation, oxidative stress and cell apoptosis |
| Q43676209 | Prior exposure to oxidized low-density lipoprotein limits apoptosis in subsequent generations of endothelial cells by altering promoter methylation |
| Q34734728 | Procyanidins are potent inhibitors of LOX-1: a new player in the French Paradox. |
| Q43206014 | Propofol protects against hydrogen peroxide-induced oxidative stress and cell dysfunction in human umbilical vein endothelial cells |
| Q58580361 | Protective Effects of Chinese Traditional Medicine Longhu Rendan against Atherosclerosis via Negative Regulation of LOX-1 |
| Q83016340 | Protective effect of α-lipoic acid on oxidized low density lipoprotein-induced human umbilical vein endothelial cell injury |
| Q47108682 | Proteomic investigation of effects of hydroxysafflor yellow A in oxidized low-density lipoprotein-induced endothelial injury |
| Q35950665 | Purification, crystallization and preliminary X-ray analysis of the ligand-binding domain of human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1). |
| Q30577193 | Radiolabelled probes for imaging of atherosclerotic plaques. |
| Q41649163 | Regulation of Coronary Endothelial Function by Interactions between TNF-α, LOX-1 and Adiponectin in Apolipoprotein E Knockout Mice |
| Q36818981 | Remnant-like lipoprotein particles impair endothelial function: direct and indirect effects on nitric oxide synthase |
| Q37216929 | Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney |
| Q38213365 | Reprint of "heated vegetable oils and cardiovascular disease risk factors". |
| Q46354788 | Rho kinase inhibitor fasudil mitigates high-cholesterol diet-induced hypercholesterolemia and vascular damage |
| Q38131300 | Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease |
| Q41541678 | Scavenger receptors of endothelial cells mediate the uptake and cellular proatherogenic effects of carbamylated LDL. |
| Q45114691 | Severity dependent up-regulations of LOX-1 and MCP-1 in early sclerotic changes of common carotid arteries in spontaneously hypertensive rats |
| Q86066160 | Simvastatin increases Prolyl-4-Hydroxylase α1 expression in atherosclerotic plaque and ox-LDL-stimulated human aortic smooth muscle cells via p38 MAPK and ERK1/2 signaling |
| Q92419631 | Soluble LOX-1: A Novel Biomarker in Patients With Coronary Artery Disease, Stroke, and Acute Aortic Dissection? |
| Q46648050 | Soluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitus |
| Q36381012 | Spotlight on endothelial progenitor cell inhibitors: short review |
| Q93009898 | Stimulus-dependent modifications in astrocyte-derived extracellular vesicle cargo regulate neuronal excitability |
| Q34314984 | Synergistic effect of local endothelial shear stress and systemic hypercholesterolemia on coronary atherosclerotic plaque progression and composition in pigs |
| Q37041786 | Telomeres and atherosclerosis |
| Q53626939 | The 1.4 angstrom crystal structure of the human oxidized low density lipoprotein receptor lox-1. |
| Q38025997 | The C-type lectin-like receptors of Dectin-1 cluster in natural killer gene complex |
| Q88789173 | The CD44-HA axis and inflammation in atherosclerosis: A temporal perspective |
| Q83311143 | The association between soluble lectin-like oxidized low-density lipoprotein receptor-1 levels and patients with isolated coronary artery ectasia |
| Q81433306 | The lectin-like oxidized low-density lipoprotein receptor and its role in atherosclerosis |
| Q38112162 | The lectin-like oxidized low-density lipoprotein receptor-1 as therapeutic target for atherosclerosis, inflammatory conditions and longevity |
| Q95805497 | The platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells |
| Q46643525 | The protective effect of bergamot oil extract on lecitine-like oxyLDL receptor-1 expression in balloon injury-related neointima formation |
| Q34059051 | The relationships between exogenous and endogenous antioxidants with the lipid profile and oxidative damage in hemodialysis patients |
| Q38248729 | The role of lectin-like oxidised low-density lipoprotein receptor-1 in vascular pathology |
| Q46363692 | Transmembrane signaling pathway mediates oxidized low-density lipoprotein-induced expression of plasminogen activator inhibitor-1 in vascular endothelial cells |
| Q37579569 | Zc3h12c inhibits vascular inflammation by repressing NF-κB activation and pro-inflammatory gene expression in endothelial cells. |
Search more.